Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 32Precursor Cell Lymphoblastic Leukemia-Lymphoma 24Leukemia 16Lymphoma, Non-Hodgkin 9Lymphoma 9Leukemia, Lymphocytic, Chronic, B-Cell 8Lymphoma, Large B-Cell, Diffuse 7Lymphoma, Mantle-Cell 6Lymphoma, B-Cell, Marginal Zone 6Lymphoma, Follicular 5Burkitt Lymphoma 5Recurrence 4Neoplasms 4Myelodysplastic Syndromes 4Lymphoma, Large-Cell, Anaplastic 4Congenital Abnormalities 4Anemia, Refractory, with Excess of Blasts 4Waldenstrom Macroglobulinemia 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Myeloproliferative Disorders 3Multiple Myeloma 3Lymphoma, Large-Cell, Immunoblastic 3Lymphoma, Extranodal NK-T-Cell 3Leukemia, Myelomonocytic, Juvenile 3Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Immunoblastic Lymphadenopathy 3Hematologic Neoplasms 3Thrombocythemia, Essential 2Sezary Syndrome 2Primary Myelofibrosis 2

Interventions

Aprepitant 7Ondansetron 6Palonosetron 3Granisetron 3Dexamethasone 3dexamethasone 21-phosphate 2Cyclophosphamide 2Calcium Dobesilate 2ramosetron 1dexamethasone acetate 1Tropisetron 1Sugars 1Olanzapine 1Immunoenzyme Techniques 1Drug Therapy 1Doxorubicin 1Control Groups 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Vomiting × Drug Therapy × Other hematologic neoplasm × Clear all
NCT02116530 2025-01-28

Antiemetic Therapy With or Without Olanzapine in Preventing Chemotherapy-Induced Nausea and Vomiting in Patients With Cancer Receiving Highly Emetogenic Chemotherapy

Alliance for Clinical Trials in Oncology

Phase 3 Completed
401 enrolled 14 charts
Other hematologic neoplasm

Nausea, Vomiting, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡